These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 108706)

  • 21. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical denervation produces supersensitivity of central serotonergic receptors involved in the control of TSH secretion in the rat.
    Schettini G; Di Renzo G; Amoroso S; Annunziato L; Quattrone A
    Brain Res; 1983 Feb; 261(2):349-52. PubMed ID: 6831219
    [No Abstract]   [Full Text] [Related]  

  • 23. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
    Applegate CD
    Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
    [No Abstract]   [Full Text] [Related]  

  • 24. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the effects of stimulation or blockade of beta-adrenoceptors on the head-twitches induced in mice by 5-hydroxytryptophan versus 5-methoxy-N, N-dimethyltryptamine.
    Martin P; Soubrié P; Simon P
    J Pharmacol; 1986; 17(2):119-25. PubMed ID: 2875219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
    Klemm HP; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():36-56. PubMed ID: 280252
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat.
    Stewart RM; Growdon JH; Cancian D; Baldessarini RJ
    Neuropharmacology; 1976 Aug; 15(8):449-55. PubMed ID: 1086442
    [No Abstract]   [Full Text] [Related]  

  • 29. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
    Pranzatelli MR; Snodgrass SR
    Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
    Carruba MO; Keller HH; Da Prada M
    Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
    Pranzatelli MR; Eng B
    Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats.
    Hoebel BG; Zemlan FP; Trulson ME; MacKenzie RG; DuCret RP; Norelli C
    Ann N Y Acad Sci; 1978 Jun; 305():590-4. PubMed ID: 152082
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration.
    Nisbet AP; Marsden CA
    Eur J Pharmacol; 1984 Sep; 104(1-2):177-80. PubMed ID: 6499914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.